Drugs that allow the immune system to recognise cancer and attack it are continuing to produce "exciting" results, say experts in the field.
Cancer Research UK to collaborate with AstraZeneca in screening for new cancer medicines at the AstraZeneca MRC UK Centre for Lead Discovery
AstraZeneca and Cancer Research UK have signed a memorandum of understanding to open access to state-of-the-art drug discovery facilities.
BACIT is seeking shareholder approval to permit an investment into the CRT Pioneer Fund, taking the total to £70m.
Excess bodyweight is behind almost half a million new cancer cases in adults each year.